The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 15, 2025

Filed:

Sep. 25, 2019
Applicant:

Surface Oncology, Llc, Redwood City, CA (US);

Inventors:

Jonathan Hill, Cambridge, MA (US);

Scott Chappel, Cambridge, MA (US);

Michael Gladstone, Cambridge, MA (US);

Bianka Prinz, Lebanon, NH (US);

Andrew Lake, Cambridge, MA (US);

Christine Miller, Cambridge, MA (US);

Kerry White, Cambridge, MA (US);

Jing Hua, Cambridge, MA (US);

Pamela M. Holland, Cambridge, MA (US);

Matthew Rausch, Cambridge, MA (US);

Devapregasan Moodley, Cambridge, MA (US);

Gege Tan, Cambridge, MA (US);

Assignee:

SURFACE ONCOLOGY, LLC, Redwood City, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/24 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01); A61P 37/04 (2006.01); C07K 16/28 (2006.01); G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
C07K 16/244 (2013.01); A61P 35/00 (2018.01); A61P 37/04 (2018.01); C07K 16/24 (2013.01); C07K 16/2803 (2013.01); C07K 16/2827 (2013.01); C07K 16/2851 (2013.01); G01N 33/574 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/33 (2013.01); C07K 2317/34 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); G01N 2333/54 (2013.01);
Abstract

The present disclosure relates to anti-IL-27 antibodies, and antigen-binding portions thereof. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the antibodies or antigen-binding portion thereof. The disclosure also relates to methods for detecting IL-27 in, for example, a subject or a sample.


Find Patent Forward Citations

Loading…